1. Home
  2. PSIX vs IMVT Comparison

PSIX vs IMVT Comparison

Compare PSIX & IMVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PSIX
  • IMVT
  • Stock Information
  • Founded
  • PSIX 1985
  • IMVT 2018
  • Country
  • PSIX United States
  • IMVT United States
  • Employees
  • PSIX N/A
  • IMVT N/A
  • Industry
  • PSIX Industrial Machinery/Components
  • IMVT Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • PSIX Industrials
  • IMVT Health Care
  • Exchange
  • PSIX Nasdaq
  • IMVT Nasdaq
  • Market Cap
  • PSIX 2.5B
  • IMVT 2.7B
  • IPO Year
  • PSIX N/A
  • IMVT N/A
  • Fundamental
  • Price
  • PSIX $84.64
  • IMVT $16.00
  • Analyst Decision
  • PSIX Strong Buy
  • IMVT Buy
  • Analyst Count
  • PSIX 1
  • IMVT 10
  • Target Price
  • PSIX $37.00
  • IMVT $33.38
  • AVG Volume (30 Days)
  • PSIX 706.3K
  • IMVT 1.7M
  • Earning Date
  • PSIX 11-08-2025
  • IMVT 11-06-2025
  • Dividend Yield
  • PSIX N/A
  • IMVT N/A
  • EPS Growth
  • PSIX 146.48
  • IMVT N/A
  • EPS
  • PSIX 4.81
  • IMVT N/A
  • Revenue
  • PSIX $597,494,000.00
  • IMVT N/A
  • Revenue This Year
  • PSIX $29.80
  • IMVT N/A
  • Revenue Next Year
  • PSIX $11.99
  • IMVT N/A
  • P/E Ratio
  • PSIX $17.54
  • IMVT N/A
  • Revenue Growth
  • PSIX 40.10
  • IMVT N/A
  • 52 Week Low
  • PSIX $15.30
  • IMVT $12.72
  • 52 Week High
  • PSIX $121.78
  • IMVT $32.10
  • Technical
  • Relative Strength Index (RSI)
  • PSIX 39.63
  • IMVT 50.79
  • Support Level
  • PSIX $90.45
  • IMVT $15.81
  • Resistance Level
  • PSIX $98.71
  • IMVT $17.15
  • Average True Range (ATR)
  • PSIX 7.92
  • IMVT 0.73
  • MACD
  • PSIX -3.15
  • IMVT 0.10
  • Stochastic Oscillator
  • PSIX 7.02
  • IMVT 57.98

About PSIX Power Solutions International Inc. Common Stock

Power Solutions International Inc is an America-based company that manufactures, distributes, and services power systems that run on nondiesel fuels, including natural gas, propane, and gasoline. The company's products are designed to meet emission standards imposed by environmental regulatory bodies like the Environmental Protection Agency. Its products are distributed to a wide range of industrial original equipment manufacturers that supply equipment to sectors including power generation, oil and gas, material handling, airport ground support, agricultural, turf, construction and irrigation. The company generates majority of its sales from United States.

About IMVT Immunovant Inc.

Immunovant Inc is a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases. Its focus is on developing IMVT-1402, a potential inhibitor of the neonatal fragment crystallizable receptor (FcRn), to address autoimmune diseases driven by high levels of pathogenic immunoglobulin G (IgG) antibodies. FcRn is involved in preventing the degradation of IgG antibodies, and inhibition of FcRn has been shown to reduce levels of total IgG and pathogenic IgG antibodies. The company operates in a single operating segment, which includes all activities related to the research, development and manufacturing of its product candidates.

Share on Social Networks: